JAC Advance Access published online on October 14, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh456
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Oral Sciences, University of Otago, PO Box 647, Dunedin, New Zealand
* To whom correspondence should be addressed. E-mail: richard.cannon{at}stonebow.otago.ac.nz.
Objectives: Information on the function of Candida albicans ATP-binding cassette (ABC) membrane transporter Cdr1p has come from studying the effect of gene inactivation in C. albicans and from heterologous Cdr1p expression in the yeast Saccharomyces cerevisiae. These approaches, however, give only an indirect indication of Cdr1p function in C. albicans itself. The objective of this study was to determine Cdr1p function in C. albicans by induced overexpression of Cdr1p in a C. albicans CDR1-deleted strain. Methods: The C. albicans CDR1 open reading frame was fused to the C. albicans HEX1 promoter and used to complement a CDR1-null mutant to create strain FL3. The effect of inducing the FL3 HEX1 promoter, by growth on medium containing N-acetylglucosamine (GlcNAc) as the carbon source, on CDR1 expression and drug susceptibility was determined. Results: C. albicans FL3 cells grown on medium containing GlcNAc overexpressed CDR1 mRNA and a 170 kDa plasma membrane protein that reacted with anti-Cdr1p antibodies. Overexpression of Cdr1p in C. albicans FL3 conferred resistance to structurally unrelated chemicals such as terbinafine, brefeldin A, cerulenin and nigericin as well as to azole antifungal agents, but not resistance to polyene antibiotics. FK506, ascomycin and ciclosporin A chemosensitized FL3 to fluconazole. FL3 cells grown on GlcNAc effluxed 5.3 times as much Cdr1p substrate rhodamine 6G, over a 10 min period, as FL3 cells grown on glucose, and this rhodamine 6G efflux was inhibited by including fluconazole in the assay. Conclusion: This study provides the first direct demonstration of Cdr1p pump activity in C. albicans. *Present address. Department of Bioactive Molecules, Institute of Infectious Diseases, Tokyo, Japan.
Revised September 8, 2004
Accepted September 12, 2004
Original article
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
2 Department of Bioactive Molecules, National Institute of Infectious Diseases, Tokyo, Japan
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. D. Cannon, E. Lamping, A. R. Holmes, K. Niimi, P. V. Baret, M. V. Keniya, K. Tanabe, M. Niimi, A. Goffeau, and B. C. Monk Efflux-Mediated Antifungal Drug Resistance Clin. Microbiol. Rev., April 1, 2009; 22(2): 291 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsao, F. Rahkhoodaee, and M. Raymond Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1344 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Holmes, Y.-H. Lin, K. Niimi, E. Lamping, M. Keniya, M. Niimi, K. Tanabe, B. C. Monk, and R. D. Cannon ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates Antimicrob. Agents Chemother., November 1, 2008; 52(11): 3851 - 3862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hiller, D. Sanglard, and J. Morschhauser Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1365 - 1371. [Abstract] [Full Text] [PDF]
|
|